Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuang Ye

Showing results (1-10 of 275) with videos related to

Pageof 28
Sort By:
The European Respiratory Journal|July 14, 2025
Reply: Tofacitinib is a step forward for management of patients with interstitial lung disease associated with anti-MDA5-positive dermatomyositisWanlong Wu, Shuang Ye
The Lancet. Rheumatology|January 27, 2024
A molecular signature as a guidance for glucocorticoid: are we there yet?Yakai Fu, Shuang Ye
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 2, 2018
Tocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic PemphigusLiyang Gu, Shuang Ye
Current Opinion in Neurology|May 3, 2008
Central nervous system infections in the systemic vasculitidesShuang Ye, Cheng-de Yang
Clinical Rheumatology|January 24, 2006
How could we make a diagnosis of Wegener's granulomatosis?Shuang Ye, Cheng-de Yang
Clinical Rheumatology|January 24, 2006
Lupus erythematosus and lupus valgaris: a case report and historical remarksShuang Ye, Cheng-de Yang
The Science of the Total Environment|February 6, 2020
Daily precipitation isotope variation in Midwestern United States: Implication for hydroclimate and moisture sourceZelalem Bedaso, Shuang-Ye Wu
Therapeutic Advances in Musculoskeletal Disease|March 7, 2022
Successful treatment of sirolimus in a Chinese patient with refractory LN and APS: a case reportDanting Zhang, Fangfang Sun, Shuang Ye
International Journal of Rheumatic Diseases|October 9, 2023
Intention to treat: The management of connective tissue disease-related immune thrombocytopeniaYakai Fu, Liling Zhao, Shuang Ye
Lupus Science & Medicine|November 5, 2025
Comparison of obinutuzumab and rituximab for treating neuropsychiatric lupus: a retrospective case-control studyHuijing Wang, Shuang Ye, Fangfang Sun
Pageof 28

Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
The European Respiratory Journal|July 14, 2025
Reply: Tofacitinib is a step forward for management of patients with interstitial lung disease associated with anti-MDA5-positive dermatomyositisWanlong Wu, Shuang Ye
The Lancet. Rheumatology|January 27, 2024
A molecular signature as a guidance for glucocorticoid: are we there yet?Yakai Fu, Shuang Ye
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|February 2, 2018
Tocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic PemphigusLiyang Gu, Shuang Ye
Current Opinion in Neurology|May 3, 2008
Central nervous system infections in the systemic vasculitidesShuang Ye, Cheng-de Yang
Clinical Rheumatology|January 24, 2006
How could we make a diagnosis of Wegener's granulomatosis?Shuang Ye, Cheng-de Yang
Clinical Rheumatology|January 24, 2006
Lupus erythematosus and lupus valgaris: a case report and historical remarksShuang Ye, Cheng-de Yang
The Science of the Total Environment|February 6, 2020
Daily precipitation isotope variation in Midwestern United States: Implication for hydroclimate and moisture sourceZelalem Bedaso, Shuang-Ye Wu
Therapeutic Advances in Musculoskeletal Disease|March 7, 2022
Successful treatment of sirolimus in a Chinese patient with refractory LN and APS: a case reportDanting Zhang, Fangfang Sun, Shuang Ye
International Journal of Rheumatic Diseases|October 9, 2023
Intention to treat: The management of connective tissue disease-related immune thrombocytopeniaYakai Fu, Liling Zhao, Shuang Ye
Lupus Science & Medicine|November 5, 2025
Comparison of obinutuzumab and rituximab for treating neuropsychiatric lupus: a retrospective case-control studyHuijing Wang, Shuang Ye, Fangfang Sun
Pageof 28